You are here

Adipose Clinical Trials

Comment

Discuss
Condition:   ARDS
Interventions:   Drug: Mesenchymal stem cells;   Drug: Placebo
Sponsor:   Shaoxing Second Hospital
Unknown status - verified July 2013
Condition:   Lateral Epicondylitis
Intervention:   Biological: ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection
Sponsor:   Seoul National University Hospital
Unknown status - verified November 2013
Condition:   Knee Osteoarthritis
Interventions:   Biological: Mesenchymal stem cells low-dose group;   Biological: Mesenchymal stem cells mid-dose group;   Biological: Mesenchymal stem cells high-dose group
Sponsors:   Cellular Biomedicine Group Ltd.;   RenJi Hospital
Completed - verified April 2016
Conditions:   Breast Neoplasms;   Skin Abnormalities
Interventions:   Biological: Adipose SVF cell;   Biological: Normal saline
Sponsor:   Seoul National University Hospital
Not yet recruiting - verified December 2016
Condition:   Spinal Cord Injury
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsors:   Biostar;   Korea University Anam Hospital
Completed - verified August 2016
Condition:   Critical Limb Ischemia
Intervention:   Other: Mesenchymal stem cells from adipose tissue
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Active, not recruiting - verified March 2017
Condition:   Keratopathy
Intervention:   Drug: Expanded adipose-derived stem cells
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Unknown status - verified September 2012
Condition:   Urinary Incontinence
Intervention:   Drug: Adipose-derived expanded stem cells
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Unknown status - verified March 2013
Condition:   Urinary Incontinence
Intervention:   Drug: Inject of Autologous Adipose-derived stem cells
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Completed - verified September 2012
Condition:   Ischemic Stroke
Interventions:   Drug: Allogenic mesenchymal stem cells from adipose tissue;   Drug: Placebo
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Recruiting - verified February 2017

Pages